V158866

DRUG2 trials

Sponsors

Vernalis (R&D) Ltd, Brigham and Women's Hospital

Conditions

First in Man StudyNeuropathic Pain Due to Spinal Cord Injury

Phase 1

Single and Multiple Ascending Dose Study of V158866 in Healthy Volunteers

CompletedNCT01634529

Vernalis (R&D) LtdFirst in Man Study

Start: 2011-03-31End: 2011-07-31Updated: 2012-07-11

Phase 2

A Safety, Tolerability and Efficacy Study of V158866 in Central Neuropathic Pain Following Spinal Cord Injury

CompletedNCT01748695

Brigham and Women's HospitalNeuropathic Pain Due to Spinal Cord Injury

Start: 2013-06-30End: 2015-07-31Updated: 2017-04-11